Lowe’s sticks by full-year forecast as sales from home professionals boost business

Lowe’s sticks by full-year forecast as sales from home professionals boost business


Lowe’s sticks by full-year forecast as sales from home professionals boost business

Lowe’s on Wednesday stood by its full-year forecast, as growing sales among home professionals helped offset slower demand from do-it-yourself customers.

The home improvement retailer came in just shy of Wall Street’s expectations for quarterly sales, but beat earnings estimates.

Shares of Lowe’s rose nearly 3% in premarket trading Wednesday.

In the company’s news release, CEO Marvin Ellison said investments in its stores, technology and customer service have helped the retailer get through “near-term uncertainty and housing market headwinds.”

Home improvement demand has been in a sluggish stretch as high interest rates and slower housing turnover ding U.S. consumers’ appetite to spend on pricier projects. Yet with its outlook, Lowe’s predicted it will snap out of the sales slump this year.

Lowe’s said it expects full-year total sales to range from $83.5 billion to $84.5 billion, which on the upper end would be higher than its total revenue of $83.67 billion for fiscal 2024. It said it projects comparable sales to be flat to up 1% year over year and earnings per share to range from approximately $12.15 to $12.40.

Here’s what the company reported for the fiscal first quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG:

  • Earnings per share: $2.92 vs. $2.88 expected
  • Revenue: $20.93 billion vs. $20.94 billion expected

In the three-month period that ended May 2, Lowe’s net income fell to $1.64 billion, or $2.92 per share, compared with $1.76 billion, or $3.06 per share, in the year-ago quarter.

Comparable sales decreased 1.7% year over year. Weather hurt sales demand, but sales on Lowe’s website and among home professionals grew, the company said in a press release.

Like Lowe’s, competitor Home Depot reaffirmed its full-year forecast earlier this week and posted year-over-year comparable sales declines. Home Depot’s fiscal first quarter also got a significant lift from SRS Distribution, a company it acquired that sells supplies to home professionals in roofing, pools and landscaping.

Both companies have tried to attract more sales from home professionals to offset softer sales with do-it-yourself customers. Lowe’s announced in April that it was acquiring Artisan Design Group, a company that provides design services and installation of flooring, cabinets and countertops for homebuilders and property managers, in a $1.3 billion deal.

This is breaking news. Please check back for updates.



Source

Fabletics launches denim as the athleisure trade loses steam
Business

Fabletics launches denim as the athleisure trade loses steam

Athletic apparel maker Fabletics is launching its first denim collection, the company announced Tuesday, signaling the once white hot athleisure category is starting to slow down. The collection, launching online and in select stores on Thursday, will include 11 styles and seven washes across both women’s and men’s. Items will be priced between $79.95 and […]

Read More
Boaz Weinstein warns of private credit’s “financial alchemy,” says problems are multiplying by the quarter
Business

Boaz Weinstein warns of private credit’s “financial alchemy,” says problems are multiplying by the quarter

A version of this article appeared in CNBC’s Inside Alts newsletter, a guide to the fast-growing world of alternative investments, from private equity and private credit to hedge funds and venture capital. Sign up to receive future editions, straight to your inbox. The problems in private credit are “multiplying by the quarter,” due in part to the […]

Read More
FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment
Business

FDA approves leucovorin as first drug for rare genetic disorder, after touting it as autism treatment

FILE PHOTO: The headquarters of the U.S. Food and Drug Administration (FDA) is seen in Silver Spring, Maryland November 4, 2009.  Jason Reed | Reuters The Food and Drug Administration on Tuesday approved a decades-old prescription vitamin called leucovorin as the first treatment for a rare genetic disorder in certain adults and children.  The move […]

Read More